Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
about
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.Remission in rheumatoid arthritis.American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis.The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission.Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?Impact of intensive treatment and remission on health-related quality of life in early and established rheumatoid arthritis.Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs.DANBIO--powerful research database and electronic patient record.Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceIt means everything: continuing normality of everyday life for people with rheumatoid arthritis in early remission.Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database.Patient's perspective of sustained remission in rheumatoid arthritis.Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration.Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.
P2860
Q34033218-F9FBBD79-86A3-4C57-9C93-B3842F273F4BQ34081946-70D1626E-37FC-499F-9806-88573DF62D3CQ35047250-3F775895-CA3F-468D-B9F8-3D75C8297AF0Q35205360-81A01E57-C50E-4CE5-8FC5-B1DE834D7F6CQ36916710-CE5519D2-F821-4753-8D00-FD5F79BDA4DAQ37010967-A121E61C-C396-4CFD-B4F9-7C61D96120EDQ37236947-F93374DE-2357-4425-B2AE-5BADDE7FC167Q37691184-25BE4205-3F21-4DA7-97DD-CFE5F29C1263Q37819496-4ED7E502-41F6-46BA-B2F1-03E4DC5F161FQ38476881-2D611277-AE15-483E-9AF6-F1C7F1E273CFQ39613407-1C17EFFC-F4F4-49B7-8A96-B1927ED26491Q40860110-63945AC9-7174-487E-B2C1-7727725FBD3BQ41595008-47EF75F9-747F-4845-8C42-17A9B6279F95Q43805423-B3785A18-671C-4CB9-8F37-4F4F77961C8EQ47563427-2A03874D-A7CA-46B6-89D5-B3C7010DD258
P2860
Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Does clinical remission lead t ...... remission criteria important?
@en
Does clinical remission lead t ...... remission criteria important?
@nl
type
label
Does clinical remission lead t ...... remission criteria important?
@en
Does clinical remission lead t ...... remission criteria important?
@nl
prefLabel
Does clinical remission lead t ...... remission criteria important?
@en
Does clinical remission lead t ...... remission criteria important?
@nl
P2093
P356
P1476
Does clinical remission lead t ...... remission criteria important?
@en
P2093
Jan Sørensen
Louise Linde
Mikkel Østergaard
P304
P356
10.3899/JRHEUM.090898
P407
P577
2010-01-15T00:00:00Z